Abstract
Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a “new” vaccine introduced in 1921, namely bacille Calmette-Guérin.
Keywords: BCG; COVID-19; SARS-CoV-2; vaccine.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Vaccine, BCG, 【초록키워드】 Vaccine, coronavirus, severe acute respiratory syndrome Coronavirus, Severe acute respiratory syndrome, respiratory, bacille Calmette-Guérin, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, introduced, 【제목키워드】 bacille Calmette-Guérin, lesson, candidate,
【저자키워드】 COVID-19, SARS-CoV-2, Vaccine, BCG, 【초록키워드】 Vaccine, coronavirus, severe acute respiratory syndrome Coronavirus, Severe acute respiratory syndrome, respiratory, bacille Calmette-Guérin, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, introduced, 【제목키워드】 bacille Calmette-Guérin, lesson, candidate,
{{{ 추상적인 }}}
중증 급성 호흡기 증후군 코로나바이러스 2 백신 개발자는 1921년에 도입된 "새로운" 백신, 즉 간균 Calmette-Guérin에서 얻은 교훈 중 일부를 고려해야 합니다.
{{ 키워드: }} BCG; 코로나바이러스감염증-19 : 코로나19; 사스 코로나바이러스 2; 백신.